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Purpose: To investigate the anti-dyslipidemic, anti-oxidant and anti-diabetic activities of the aqueous 
extract and solvent fractions of A. violacea flowers.                                                                                                            
Methods: The aqueous extract was fractionated into petroleum ether, ether, chloroform, chloroform-
methanol (4:1) and chloroform-methanol (3:2) fractions. Lipid lowering activity was evaluated in two 
models, viz, triton WR-1339 - induced hyperlipimea in rats as well as fructose-rich high fat diet. To 
assess anti-oxidant activity, in-vitro model of non-enzymic superoxide hydroxyl radicals and microsomal 
lipid peroxidation by non-enzymic inducer was adopted. Hypoglycemic activity was evaluated by 
sucrose-loaded rat model.                                                                             
Results: Amongst the fractions, ether and chloroform fractions caused marked decrease in the levels of 
total cholesterol (Tc), triglycerides (Tg), plasma lipids (Pl), and protein by 24, 23, 23 and 22 %, and 24, 
22, 23 and 19 %, respectively. In rats fed with high fat diet (HFD), ether and chloroform fractions 
lowered Tc, Tg and, Pl by 26, 25 and 26 %, and 18, 19 and 20 %, respectively. Significant decrease in 
superoxide anions, hydroxyl radicals and microsomal lipid peroxidation by ether and chloroform fractions 
was also observed. Chloroform, chloroform-methanol (4:1) and chloroform-methanol (3:2) fractions 
showed antihyperglycaemic activity to the extent of 25.2, 21.6 and 23.2 %, respectively.                  
Conclusion: The flowers of this plant, especially the ether and chloroform extracts, may be suitable as 
an anti-oxidant supplement for lipid management.  
 
 
Keywords: Allamanda violacea flowers, Anti-hyperlipidemic, Anti-hyperglycemic, Anti-oxidant. 
 
 





*Corresponding author:  Email: alkaarunsethi@rediffmail.com; Tel: 91-9415396239 
Sethi et al 




Atherosclerosis is the major cause of heart 
diseases, stroke and death in both developed 
and developing countries. It is well 
established that elevated levels of low density 
lipoproteins constitute primary risk factors for 
atherosclerosis. Epidemiological studies have 
indicated that dyslipidemia and coagulation 
disturbances are among the most significant 
risk factor for the development of 
atherosclerotic conditions [1] 
 
Current pharmacological treatment of 
atherosclerosis includes the use of the statin 
class of 3-hydroxy-3-methyl glutaryl.CoA 
(HMG.CoA) reductase inhibitors and the 
fibrate class, peroxisome proliferator-
activated receptor alpha (PPARα) 
antagonists. They are effective in lowering 
triglyceride (Tg) and low density lipoprotein 
(LDL) but most patients still experience 
coronary events despite statin therapy. In 
addition, there are reports of undesirable side 
effects (myopathy) of some ‘super statins’ 
whereby the scope for improving the potency 
of this class of drug may be modest [2]. 
Furthermore, the fibrate class of drugs, which 
are mostly used to treat hypertriglyceridemia 
and low HDL cholesterol, requires high doses 
to show significant efficacy [3]. In addition, a 
combination of fibrate and statin has met with 
serious safety concerns as exemplified by the 
withdrawal of cerivastatin in 2001. Besides, 
hyperglycemia and dyslipidemia, which are 
the two major components of metabolic 
syndrome, are also one of the crucial risk 
factors for cardiovascular diseases [4]. 
Therefore, there is a need for a different class 
of compounds to treat hyperglycemia and 
dyslipidemia without the attendant serious 
side effects.   
 
Oxidative stress has recently been implicated 
in the pathogenesis of various diseases such 
as diabetes and coronary artery diseases. 
Hydroxyl free radical (.OH) has also been 
found to be responsible for the peroxidative 
damage to lipoproteins present in the blood, 
which in turn are responsible for the initiation 
and progression of atherosclerosis [5]. 
Therefore, treating both oxidative stress and 
disorders of lipid metabolism together, may 
be a novel approach to regress 
atherosclerosis and other cardiovascular 
diseases. We reported earlier that some 
precursors in hormone synthesis, such as, 
guggulsterone, possess lipid-lowering 
activity, together with mild anti-oxidant effect 
and also inhibit oxidative modification of LDL 
[6]. Recently, we also found that some 
pregnane derivatives exhibited antioxidant 
and anti-dyslipidemic activities simulta-
neously [7,8]. 
 
A. violacea (purple allamanda, violet 
allamanda, syn A. blanchetti) is an 
ornamental plant of Allamanda genus in the 
Apocyanaceae family. Previous 
phytochemical examination of this plant 
indicated the presence of plumericin, 
isoplumericin and 5, 6-dimethoxycoumarin 
[9]. The ethanol extracts of the roots, leaves 
and stems of this plant have been reported to 
posses’ cytostatic and cytotoxic activities 
[10]. However, no work has been reported on 
the flowers of this plant. The present study 
was undertaken to evaluate the anti-
dyslipidemic, anti-oxidant and anti-diabetic 
activities of the extract and fractions of the 




Chemicals and reagents 
 
 All the chemicals/solvents used were of  high 
purity (AR/GR grade) and all the solvents 
used were dried by standard procedures. 
Triton WR-1339 was purchased from Sigma 
Chemical Company, St Louis, MO, USA and 
high fat diet (HFD) from Research Diet Inc, 
New Brunswick, USA (Product code no. D 
99122211). Triglyceride (Tg) test kits and 
total cholesterol (Tc) test kits were purchased 
from Merck Co. 
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Experimental animals 
 
Rats (Charles Foster strain, male, adult, body 
weight 200 – 225 g) were kept in a room with 
controlled temperature (25 – 26 oC), humidity 
(60 – 80 %) and 12/12 h light/dark cycle in 
hygienic conditions. Animals, which were 
acclimatized for one week before starting the 
experiment, had free access to normal diet 
and water ad libitum [7,8]. 
 
Central Drug Research Institute Animal 
Ethics Committee approved the animal 
studies (approval ref no. 120/10/ 
Biochem/IAEC) which also followed 
Committee for the Purpose of Control and 
Supervision on Experiments on Animals 
(CPCSEA) guidelines as well as those of 
GLP Annual Welfare Board, Government of 
India.   
 
Preparation of extract 
 
The whole plant of A. violaceae was collected 
in the month of October 2010 from Lucknow, 
India. The identity of the plant was confirmed 
by Dr Tariq Hussain, Head, Department of 
Taxonomy and Herbarium, National Botanical 
Research Institute, Lucknow, India, where a 
voucher specimen, no. 97108, was 
deposited.  
 
The flowers of the plant were shade-dried, 
powdered, soaked in water overnight and 
exhaustively extracted by percolation with 
ethanol of increasing concentration from 50 
to 95 % at room temperature [11]. The 
combined alcoholic extract was concentrated 
in a rotator evaporator under reduced 
pressure to get the hydroalcohol extract. The  
hydroalcohol extract was shaken success-
sively with petroleum ether (Pet Et2O, 35 oC, 
1000 ml x3), ether (Et2O,  1000 ml x3), 
chloroform (CHCl3,  1000 ml x3), chloroform: 
methanol (CHCl3:CH3OH, 4:1, 1000 ml x3), 
chloroform: methanol (CHCl3:CH3OH, 3:2, 
1000 ml x3) for preliminary separation of the 
constituents of different polarities. The 
fractionation was carried out at room 
temperature and the organic layer was 
removed from the separating funnel only 
when there was a separation of a clear layer. 
After fractionation was complete, the residue 
was discarded.    
 
Phytochemical screening of extract 
fractions 
 
High performance liquid chromatography 
(HPLC) analyses was carried out on a 
Waters HPLC system, equipped with Waters 
717 plus auto sampler, Waters 2998 
photodiode array detector (PDA), using 
Column aquasil C-18 (250 mm × 4.6 mm). 
The results were analysed by Empower 2 
software, Build 2154. Samples were eluted in 
a linear gradient of water and acetonitrile. 
(80:20, v/v) as the mobile phase. Flow rate 
was constantly kept at 0.8ml/min. The UV 
spectrum of the petroleum ether, ether and 
chloroform  fractions showed absorption 
bands in the range of 200.8 - 322.2 nm, 
200.8 - 375.6 nm and 212.5 - 294.9 nm, 
respectively, corroborating the presence of 
flavonoids/sterols/ terpenes in these extracts 
[12,13]. The chloroform-methanol (4:1) and 
chloroform-methanol (3:2) showed absorption 
bands in the range 257.2 - 293.8 and 256.0 - 
260.7 nm, respectively, indicating the 
absence of steroids/triterpnoids and 
flavonoids and possibly, phenolic 
compounds. 
 
Assessment of triton- and cholesterol-
induced hyperlipidemia 
 
The rats were divided into nine treatment 
groups of six rats each, namely, control, 
triton-induced, triton + hydroalcohol extract, 
triton + petroleum ether fraction, triton + ether 
fraction, triton + chloroform fraction, triton + 
chloroform:methanol (4:1) fraction, triton + 
chloroform: methanol (3:2) fraction and triton 
+ drug (gemfibrozil, 100 mg/kg). Hyperli-
pidemia was developed over an 18-hour 
period by administration of triton WR-1339 
(Sigma, St. Louis, MO, USA) at a dose of 400 
mg/kg intraperitoneally to all the animals 
except control.  Fractions/extracts were 
triturated with 0.2 %w/v aqueous gum acacia 
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suspension, and fed orally (100 mg/kg) and 
simultaneously with triton, after further 
feeding was stopped. Control and triton 
groups, which did not receive fraction/extract 
treatment, received the same amount of gum 
acacia suspension (vehicle). After 18 h of 
treatment, the animals were anaesthetized 
with thiopentone sodium (50 mg/kg) prepared 
in normal saline and then 2 mL blood was 
withdrawn from the retro-orbital sinus using 
glass capillary in EDTA-coated Eppendorf 
tube (3 mg/ml blood). The blood was 
centrifuged at 2500 g and 4 oC for 10 min to 
separate plasma. The plasma was diluted 
with normal saline (1:3) and used for analysis 
of total cholesterol (Tc), triglycerides (Tg) and 
phospholipids (Pl) by standard enzymatic 
methods [14].  
 
In the chronic experiment, hyperlipemia was 
produced by feeding with high fat diet (HFD) 
once a day for 30 days. The fraction/extract 
was administered (50 mg/kg) orally 
simultaneously with HFD to the extract-
treated groups. The control animals received 
the same amount of normal saline (2.5 ml/kg)  
or arachis oil (5 ml/kg). At the end of the 
experiment, the rats were fasted overnight 
and blood (2 mL) was withdrawn. The 
animals were killed and their liver promptly 
excised. The plasma was analyzed for Tc, 
Tg, Pl, lecithin-cholesterol acyltransferase 
activity (LCAT) and post-heparin lipase 
activity (PHLA) activity. 
 
Assessment of antioxidant activity 
 
Superoxide anions (O-2) were generated 
enzymatically [14] by xanthine (160 mM), 
xanthine oxidase (0.04 U) and nitroblue 
tetrazolium (320 μM) in the absence or 
presence of the fraction/extract (400 μg/ml) in 
100 mM phosphate buffer (pH 8.2). The 
fractions were sonicated well in phosphate 
buffer before use. The reaction mixtures were 
incubated at 37 oC and after 30 min, the 
reaction was stopped by adding 0.5 mL 
glacial acetic acid spectrophotometrically. 
Inhibition (%) was calculated by determing 
the absorption coefficient of formazone as 7.2 
× 103 M-1cm-1.  
 
In another set of experiments, the effect of 
petroleum ether, ether, chloroform, 
chloroform-methanol (4:1) and chloroform: 
methanol (3:2) fractions/extracts on the 
generation of hydroxyl radicals (.OH) was 
studied by non-enzymic reactants [14]. Briefly 
.OH was generated in a non-enzymic system 
comprised of deoxyribose (2.8 mM), 
FeSO4.7H2O (2 mM), sodium ascorbate (2.0 
mM) and H2O2 (2.8 mM) in 50 mM KH2PO4 
buffer (pH 7.4) to a final volume of 2.5 mL. 
The reaction mixtures above, in the absence 
or presence of the fractions/extracts (400 
μg/ml) were incubated at 37 oC for 90 min. 
Reference tubes and reagent blanks were 
also run simultaneously. Malondialdehyde 
(MDA) content in both experimental and 
reference tubes were estimated using 
thiobarbituric acid method with a 
spectrophotometer as stated above [14]. 
 
Assessment of antihyperglycaemic 
activity 
 
Male albino rats of Charles Foster strain with 
mean body weight of 160 ± 20 g were 
selected for this study. The blood glucose 
level of each animal was checked with the 
help of glucometer (Boehringer Mannheim) 
after 16 h starvation. The animals showing 
blood glucose level between 3.33 and 4.44 
mM (60 - 80 mg/dl) were divided into eight 
groups of five animals each. The test group 
was administered a suspension of the extract 
orally (formulated in 1 % gum acacia) at a 
dose of 100 mg/kg while the control group 
received an equal amount of 1 % gum acacia 
(400 μl) only. A sucrose load (10 g/kg) was 
given to the animals in both groups orally 30 
min later, to evaluate the decrease in the 
postprandiol rise in blood glucose [15]. The 
blood glucose profile of the rats was 
determined at 30, 60, 90 and 120 min after 
extract/vehicle administration with a 
glucometer. Food, but not water, was 
withheld from the animals during the course 
of experimentation [15].  
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Statistical analysis 
 
Data were analyzed using Student’s t-test. 
Hyperlipidemia groups were compared with 
control and extract-treated groups. In the 
other experiments, the extract groups were 
compared with the reference group. Similarly, 
the generation of oxygen-free radicals with 
different solvent fractions was compared with 
that of the unfractionated extract. Quantitative 
glucose tolerance of each animal was 
calculated by trapezoid method using Prism 
software. (version 3, GraphPad software, 





The yield of the various fractions was as 
follows: petroleum ether (0.052 %), ether 
(0.115 %), chloroform (0.970 g, 0.092 %), 
chloroform:methanol (4:1, 0.083 %), 
chloroform:methanol (3:2, 0.068 %) 
These solvent fractions/extracts were 
subjected to phytochemical tests for 
carbohydrates and/or glycosides, flavonoids, 
and sterols and/or terpenes. petroleum ether, 
ether and chloroform fractions gave positive 
Libermann Burchardt test (for steroids and/or 
terpenes) [16], liquid ammonia, NaOH and 
Shinoda test (for flavones) [17, 18], Feigl test 
(for normal sugars) [19], Vanillin perchloric 
acid test (for 2-deoxy and 6-deoxy sugars) 
[20], indicating the presence of 
flavones/sterols/terpenes in free state or in 
the form of their glycosides. However, 
chloroform-methanol (4:1) and chloroform–
methanol (3:2) fractions gave only positive 
Feigl, vanillin perchloric acid and NaOH test, 
indicating the likely presence of phenols in 
the free state or in the form of their 
glycosides. 
 
Table 1 shows that administration of triton 
WR-1339 caused a marked increase in the 
serum levels of Tc (+2.19-fold), Tg (+2.66-
fold), Pl (+2.66-fold), protein (+1.79-fold), and 
a decrease in PHLA (-32 %) 
 
 
Table 1: Lipid lowering activity of extracts /fractions of A. violacea flowers in triton-treated           
hyperlipidemic rats (mean ± standard deviation, n = 6). 
Treatment Total 
Cholesterola 






Control 94.187.21 95.597.11          84.346.82            06.720.04       16.661.14 
Triton treated     206.8817.33  
(+2.19F)***          
255.1518.92  
(+2.66F)***           
225.1620.00 
(+2.66F)***                   
12.061.03 
(+1.79F)***         
11.310.80 
(-32)***    












































































Unit: amg/dl, bg/dl, cnmol FFA formed /hr/L.*p  0.05, **p  0.01, ***p  0.001, NS = not significant. 
Triton-treated group was compared with control. Triton + drug-treated groups compared with triton only.
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Varying but significant decrease in lipid levels 
was noticed following treatment of 
hyperlipidemic rats with the extracts/fractions 
of A. violaceae flowers at an oral dose of 100 
mg/kg. Ether and chloroform fractions 
decreased the levels of Tc, Tg, Pl, and 
protein by 24, 23, 23, 22 % and 24, 22, 23, 
19 %, respectively, while petroleum ether, 
chloroform: methanol (4:1) and chloroform: 
methanol (3:2) fractions showed mild lipid-
lowering activity as compared to triton. On 
the other hand, the standard drug 
(gemfibrozil), at the same dose (100mg/kg) 
decreased the plasma levels of Tc, Tg, Pl, 
and protein by 36, 32, 34, and 27 %, 
respectively. Post-heparin lipolytic activity 
was partially activated in the plasma of the 
hyperlipidemic rats, producing a significant 
inhibition of 26 %. However, gemfibrozil 
caused a significant reversal of the lecithin-
cholesterol acyltransferase (LCAT) activity 
and post heparin lipase activity (PHLA) 
(Table 1). 
 
In the high-fat diet (HFD) model (Table 2), 
feeding the rats with high-fat diet once a day 
for 30 days produced hyperlipidemia as 
evidenced by increase in the plasma levels of 
Tc (+ 3.55-fold), TG (+ 2.44-fold) and Pl (+ 
2.86-fold). The ether and chloroform extracts 
showed potent lipid-lowering activity, 
decreasing Tc, Tg, Pl and protein by 25, 26, 
27, 23 %, and 23, 22, 21, 22 %, respectively. 
 
The antioxidant activities of the 
extracts/fractions are shown in Table 3. 
There was significant inhibition of superoxide 
anions by (7 - 32 %), hydroxyl radicals (15 - 
36 %) and microsomal lipid peroxidation (13 - 
35 %) in non enzymatic system compared to 
that of extracts.  
 
Table 2: Lipid-lowering activity of extracts/ fractions of A. violacea flowers in hyperlipidemic rats 
 
Treatment Total Cholesterola 
(Tc) 
Triglyceridea 
      (Tg) 
Phospholipidsa 
        (Pl) 
Proteinb 




















































































Unit: amg/dl, bg/dl.*p  0.05,**p  0.01,***p  0.001, NS = not significant. Cholesterol-fed hyperlipidemic 
groups were compared with control.Cholesterol + drug-treated groups with HFD only. 
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Table 3: Effect of extracts/ fractions of A. violacea flowers on generation of free radical and lipid 
peroxidation in rat liver microsomes in vitro (% change in values of parameter is shown in parenthesis) 
 
Treatment Conc. 











Exp 151.38 12.00(-13)*  
Exp 133.47 11.00(-23)**   
Exp 84.87 6.00(-15)* 
Exp 75.66 5.77(-25)***   
Exp 75.88 5.38(-8)NS 
Exp 70.00 6.00(-16)* 




Exp 156.06 12.22(-7)NS 
Exp 144.46 11.92(-13)* 
Exp 101.66 8.00(-11)* 
Exp 93.29 6.80(-18)** 
Exp 90.44 8.00(-8)NS 
Exp 76.40 5.82(-23)*** 
Ether  Control 169.92 13.32 Control 110.22 7.79 Control 100.39 8.24 
 100 Exp 130.30 10.88(-23)*** Exp 80.19 6.90(-27)*** Exp 80.11 6.37(-20)** 
 200 
 
Exp 114.88 8.88(-32)***   Exp 70.50 5.70(-36)*** Exp 65.22 4.00(-35)*** 
CHCl3  Control 168.15 12.66 Control 129.81 11.11 Control 96.40 8.00 
 100 Exp 132.66 11.00(-21)** Exp 115.90 8.77(-11)* Exp 80.37 6.77(-17)* 
 200 
 
Exp 120.27 9.88(-28)*** Exp 95.57 6.94(-26)*** Exp 70.22 5.33(-27)*** 
CHCl3:MeOH 
(4:1) 
 Control 152.76 12.70   Control 124.78 10.11 Control 102.30 8.11 
 100 Exp 136.00 9.84(-11)* Exp 115.57 9.66(-7)NS   Exp 88.77 6.11(-13)* 
 200 
 
Exp 126.33 10.82(-17)** Exp 105.85 6.94(-15)*    Exp 78.44 5.33(-23)*** 
CHCl3:MeOH 
(3:2) 
 Control 170.89 13.90 Control 113.06 9.84 Control 89.34 7.11 
 100 Exp 157.03 11.78(-8)NS Exp 90.13 7.80(-20)** Exp 83.38 6.24(-7)NS 
 200 
 
Exp 148.58 10.44(-13)* Exp 88.66 4.17(-21)** Exp 77.70 5.37(-13)* 
Standard 
drug 
 Control 90.38 7.12 Control 75.22 5.87 Control 88.37 9.14 
 
  Exp 20.50 1.66(-77)**      Exp 41.30 1.75(-45)*** Exp 41.83 3.14(-53)*** 
  (Alloperinol) (Mannitol) (-tocopherol) 
Units: a nmol formazone formed/minute,bn mole MDA/h. *p  0.05, **p  0.01, ***p  0.001, NS = not 
significant. Reference (standard drug) compared to the systems without drug treatment. 
 
Table 4: Antihyperglycaemic activity (mean ± SEM) of the extracts/fractions of A. violacea flowers in 
sucrose-loaded rat model 
 




Control 14270 ± 451  
Aqueous extracta 11680 ± 194 18.2* 
Pet ether extracta 12340 ± 304 13.5 
Ether extracta 12280 ± 286 13.9 
Chloroform extracta 10670 ± 185 25.2* 
Chloroform-methanol(4:1) extracta 11200 ± 340 21.5* 
Chloroform-methanol(3:2) extracta 10960 ± 307 23.2* 
Glybenclamideb   9526 ± 313 33.2** 
*p < 0.05, **p < 0.01. a100mg/kg dose, b25 mg/kg dose. Note: AUC was based on fasting blood glucose 
(FB glucose).  
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Table 4 presents the antihyperglycaemic 
activity of the extract/fractions based on the 
sucrose-loaded rat model. It is evident from 
the results that 18.2, 13.5, 13.9 % (p < 0.05), 
25.2 % (p < 0.05)  21.6 % (p < 0.05) and  
23.2 % (p < 0.05) reduction in glucose area 
under curve (AUC) was achieved by 100 
mg/kg dose of aqueous, petroleum ether, 
ether, chloroform, chloroform-methanol (4:1) 
and chloroform-methanol (3:2) extracts/ 
fractions. By comparison, the reference 
standard drug glybenclamide (25mg/kg), 





Triton WR-1339 acts as a surfactant, 
suppresses the action of lipases and blocks 
the uptake of lipoproteins by extrahepatic 
tissues, thus resulting in increase in the 
levels of circulatory lipids [7]. Furthermore, 
triton WR-1339 is known to cause structural 
modifications in circulatory lipoproteins, which 
hinder their interaction with capillary 
lipoprotein lipases.[21] It is probable that the 
extracts/fractions might have interfered with 
clustering lipoproteins coated with triton [21]. 
In this way, lipoprotein may get freely 
catabolized by these enzymes. 
 
The stimulation of plasma lecithin-cholesterol 
acyltransferase LCAT and hepatic lipases is 
the mechanism responsible for a significant 
lowering of β-lipoprotein lipid. Though the 
ether and chloroform extracts caused 
significant decrease in the plasma levels of 
lipids in triton as well as HFD models of 
hyperlipidemia, their effects were 
comparatively less than that of the standard 
drug, gemfibrozil. 
Hyperlipidemia may also induce other 
abnormalities such as oxidation of fatty acids, 
leading to the formation of ketonic bodies as 
well as liver and muscle resistance to insulin, 
which initiates the progression of diabetes in 
patients [7]. The effect of these 
extracts/fractions on triglyceride lowering was 
also observed through reversal of post-
heparin treated animals. There is a significant 
correlation between the ability of tissue to 
incorporate free fatty acid by hydrolysis of 
lipoprotein triacylglycerol and the enzyme, 
lipoprotein lipase [22]. The extracts/fractions 
inhibited cholesterol biosynthesis and 
potentiated the activity of lipolytic enzymes to 
early clearance of lipids from circulation in 
triton-induced hyperlipidemia. The data 
obtained indicate restoration of PHLA activity 
following treatment with the extracts/fractions. 
Furthermore, due to increase in 
hyperglycemia, non-enzymic glycosylation 
occurred, accompanied by glucose oxidation. 
These reactions, being catalyzed by Cu2+ and 
Fe2+, resulted in the formation of O2- and .OH 
radicals, which further accelerates the risk of 
cardiac diseases in dyslipidemic patients [23]. 
The extracts/fractions evaluated in this study 
may inhibit oxidative modification of LDL and 
thus accelerate the turnover of LDL-
cholesterol in liver [24].  
 
The involvement of hydroxyl free radical 
(.OH) has been found to be a major causative 
factor for peroxidative damage to lipoproteins 
and this is responsible for inhibition and 
progression of atherosclerosis in 
hyperlipidemic subjects [5]. The potentially 
reactive derivatives of oxygen, known as 
reactive oxygen species (ROS), such as 
superoxide radical, hydroxyl radical and 
hydrogen peroxide are continuously 
generated inside the human body as a 
consequence of exposure to exogenous 
chemicals and/or a number of endogenous 
metabolic processes involving redox 
enzymes and bioenergetics electron transfer 
[25]. The antioxidant and free oxygen radical 
scavenging activities of the extracts/fractions 
more probably appear to be mediated 
through metal ion chelators and xanthine 
oxidase inhibitors [26]. 
 
Antihyperglycaemic activity in sucrose-loaded 
normoglycemic rat model is usually due to 
insulin secreteceous, insulin sensitizing, 
insulin mimetic activities, etc. The 
extracts/fractions probably have insulin 
secreteceous activity as its activity compare 
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with that of glybenclamide, which is insulin 
secretaceous [27]. 
 
A drug with multi-fold activity that includes 
antioxidant, antidiabetic and lipid lowering 
effects such as demonstrated the 





Findings from this study suggest that the 
flowers of A. violacea, in particular, the ether 
and chloroform fractions, have good 
potentials for lipid management. However, 
further investigations to isolate and identify 
antihyperlipidemic and antioxidant principles 
in the plant as well as elucidate its mode of 
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